Evaluation of gut motility in type II diabetes by the radiopaque marker method-Reference-Cited by-同舟云学术

Evaluation of gut motility in type II diabetes by the radiopaque marker method

Published:2000-04 Issue:4 Volume:15 Page:381-385
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Iida Motoyuki¹,Ikeda Masahiko¹,Kishimoto Michihiko¹,Tsujino Takafumi¹,Kaneto Hideaki¹,Matsuhisa Munehide¹,Kajimoto Yoshitaka¹,Watarai Takao¹,Yamasaki Yoshimitsu¹,Hori Masatsugu¹

Affiliation:

1. Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1440-1746.2000.02076.x

Reference33 articles.

1. Gastric emptying of solid meals in diabetes.;Scarpello JHB;Br. Med. J.,1974

2. Gastrointestinal Manifestations of Diabetes

3. GASTROINTESTINAL PROBLEMS IN DIABETES

4. Gasatric emptying in diabetes: an overview.;Horowitz M;Diabet. Med.,1996

5. Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions;Clinical Pharmacokinetics;2024-05-31

2. Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects;Pharmaceutics;2024-02-05

3. Pan-alimentary assessment of motility, luminal content, and structures: an MRI-based framework;Scandinavian Journal of Gastroenterology;2023-07-10

4. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract;European Journal of Clinical Investigation;2022-08-08

5. Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes;Frontiers in Pharmacology;2020-12-17